HP and chronic obstructive pulmonary disease: The focus of the present study was to use mass spectrometry and bioinformatics to identify future biomarker candidates that are specific to COPD exacerbation and does not indicate generalized inflammation like the existing acute phase reactants projected as COPD biomarkers, namely haptoglobin, serum amyloid protein, RAGE and so on.